Attan personal page - To The Moon

Attan

Attan

No personal profile

4Follow

0Followers

0Topic

0Badge

2022-02-17

Wow 😎

2 Warren Buffett Stocks to Buy and Hold Forever

2022-01-10

Tell me your opinion about this news...

Sorry, the original content has been removed

2022-01-24

☕️😎✔️

Sorry, the original content has been removed

2022-01-10

OMG 😳

Sorry, the original content has been removed

2021-12-23

👍

Novavax says COVID vaccine triggers immune response to Omicron variant

2022-03-21

Why my account still under review? any chance to activate real account please help

Sorry, the original content has been removed

2022-01-11

Cool 😎

Sorry, the original content has been removed

2021-12-23

Good guide

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4100837542174330,"uuid":"4100837542174330","gmtCreate":1637734475228,"gmtModify":1638163417190,"name":"Attan","pinyin":"attan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":4,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9034178284,"gmtCreate":1647838020118,"gmtModify":1676534270573,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Why my account still under review? any chance to activate real account please help","listText":"Why my account still under review? any chance to activate real account please help","text":"Why my account still under review? any chance to activate real account please help","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034178284","repostId":"1148619313","repostType":2,"repost":{"id":"1148619313","pubTimestamp":1647827602,"share":"https://ttm.financial/m/news/1148619313?lang=&edition=fundamental","pubTime":"2022-03-21 09:53","market":"us","language":"en","title":"5 Well-Known 'Strong Buy' Stocks Trading Under $10 With Gigantic Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1148619313","media":"24/7 wall street","summary":"While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safe","content":"<html><head></head><body><p>While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the biggest public companies, especially the technology giants, trade in the hundreds, all the way up to over $1,000 per share or more. At those steep prices, it is difficult to get any decent share count leverage.</p><p>Many investors, especially more aggressive traders, look at lower-priced stocks as a way not only to make some good money but to get a higher share count. That can really help the decision-making process, especially when you are on to a winner, as you can always sell half and keep half.</p><p>We screened our 24/7 Wall St. research database looking for smaller cap companies that could very well offer patient investors some huge returns for the rest of 2022 and beyond. Skeptics of low-priced shares should remember that at one point both Amazon and Apple traded in the single digits. One stock we featured over the years, Zynga, recently was purchased by Take-Two Interactive.</p><p>While all five stocks are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><h2>ADT</h2><p>This top security company is a well-known protector of homes and businesses. ADT Inc. (NYSE: ADT) is the largest residential and second-largest commercial security monitoring company in North America. The company serves over 7 million customers, installing over a million systems per year. Roughly 94% of revenue is generated in the United States, with the remainder from Canada.</p><p>Google announced last year that it was buying a 6.6% stake in the home security firm for $450 million in a deal that will allow it to provide service to customers of its Nest home security devices. ADT said that the companies will work to combine Nest products like cameras, thermostats, doorbells and alarm systems with ADT’s installation, service and professional monitoring network. The company expects to expand the integration this year and beyond.</p><p>RBC Capital Markets has resumed coverage of ADT stock with a $12 price target. The consensus target is $10.89. The shares closed trading on Friday at $7.57.</p><h2>Arcos Dorados</h2><p>This company may be way under the radar, but it has one of the best products imaginable in terms of name recognition. Arcos Dorados Holdings Inc. (NYSE: ARCO) is the world’s largest independent McDonald’s franchisee.</p><p>The company has the exclusive right to own, operate and grant franchises of McDonald’s restaurants in 20 countries and territories in Latin America and the Caribbean, including Brazil, Colombia, Costa Rica, Mexico, Puerto Rico, the U.S. Virgin Islands and Venezuela. As of December 31, 2020, it operated or franchised 2,236 restaurants.</p><p>Credit Suisse’s $9.50 price target is above the $8.09 consensus target on Arcos Dorados stock. Shares last traded at $8.04 on Friday up almost 7%.</p><h2>Lantronix</h2><p>This company is producing solid revenue and is a great idea for aggressive traders. Lantronix Inc. (NASDAQ: LTRX) provides software as a service (SaaS), engineering services, and hardware for edge computing, the Internet of Things (IoT), and remote environment management (REM) in the Americas, Europe, the Middle East, Africa, and the Asia Pacific Japan.</p><p>The company’s IoT products include IoT Connectivity, which provides wired and wireless connections that enhance the value and utility of modern electronic systems and equipment through secure network connectivity, application hosting, protocol conversion, secure access for distributed IoT deployments, and various other functions.</p><p>Further, its SaaS platform enables customers to deploy, monitor, manage and automate across their global deployments through a single platform login. The company offers its products through value-added resellers, systems integrators, distributors, online retailers and original equipment manufacturers, and it has an e-commerce site for direct sales. Lantronix was founded in 1989 and is headquartered in Irvine, California.</p><p>The $13 Canaccord Genuity price objective compares with a $12.69 consensus target. Lantronix stock traded on Friday at $6.58 down over 4%.</p><h2>Limelight Networks</h2><p>This stock looks to have bottomed recently, and it could be ready for a sizable move higher. Limelight Networks Inc. (NASDAQ: LLNW) offers services and solutions for businesses to deliver their digital content across the internet, mobile, social and other digital initiatives. It operates edge services platform that provides content delivery services, video content management services, performance services for website and web application acceleration and security, professional services, cloud storage and edge computing services, as well as sells equipment.</p><p>Limelight Networks also offers professional services and other infrastructure services, such as transit and rack space services. It serves media companies operating in the television, music, radio, newspaper, magazine, movie, gaming, software and social media industries, as well as enterprises, technology companies and government entities conducting business online.</p><p>A recent upgrade of Limelight Networks stock at Northland Capital included the $5 price target hiked to $6.50. The consensus target is $5.50, and the shares last traded at $4.78 on Friday.</p><h2>Nokia</h2><p>This telecommunications company ruled the cell phone arena until the advent of the smartphone in 2007 and recently re-emerged as a top meme stock. Nokia Corp. (NYSE: NOK) owns two main businesses: 1) Nokia Networks, a network infrastructure equipment supplier to global wireless and wireline operators, and 2) Technologies, its patent/IPR licensing activities.</p><p>In a very positive sign for investors this past week, the company restarted its quarterly dividend and initiated a share buyback program after reporting very solid fourth-quarter results, with comparable operating earnings above market estimates as the telecom equipment maker kept costs in check. Nokia also forecasted annual revenue that was largely ahead of projections and set a long-term target for operating margins of at least 14%, replacing its earlier 2023 target of between 11% and 13%.</p><p>Raymond James upgraded Nokia stock recently and has a $6.50 target price. That is lower than the $7.23 consensus target but higher than a last share price of $5.33 seen on Friday.</p><p>These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.</p></body></html>","source":"lsy1620372341666","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Well-Known 'Strong Buy' Stocks Trading Under $10 With Gigantic Upside Potential</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Well-Known 'Strong Buy' Stocks Trading Under $10 With Gigantic Upside Potential\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-21 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://247wallst.com/investing/2022/03/19/5-well-known-strong-buy-stocks-trading-under-10-with-gigantic-upside-potential/><strong>24/7 wall street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the ...</p>\n\n<a href=\"https://247wallst.com/investing/2022/03/19/5-well-known-strong-buy-stocks-trading-under-10-with-gigantic-upside-potential/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LTRX":"创力","ARCO":"Arcos Dorados Holdings","ADT":"Adt Inc.","NOK":"诺基亚"},"source_url":"https://247wallst.com/investing/2022/03/19/5-well-known-strong-buy-stocks-trading-under-10-with-gigantic-upside-potential/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148619313","content_text":"While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the biggest public companies, especially the technology giants, trade in the hundreds, all the way up to over $1,000 per share or more. At those steep prices, it is difficult to get any decent share count leverage.Many investors, especially more aggressive traders, look at lower-priced stocks as a way not only to make some good money but to get a higher share count. That can really help the decision-making process, especially when you are on to a winner, as you can always sell half and keep half.We screened our 24/7 Wall St. research database looking for smaller cap companies that could very well offer patient investors some huge returns for the rest of 2022 and beyond. Skeptics of low-priced shares should remember that at one point both Amazon and Apple traded in the single digits. One stock we featured over the years, Zynga, recently was purchased by Take-Two Interactive.While all five stocks are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.ADTThis top security company is a well-known protector of homes and businesses. ADT Inc. (NYSE: ADT) is the largest residential and second-largest commercial security monitoring company in North America. The company serves over 7 million customers, installing over a million systems per year. Roughly 94% of revenue is generated in the United States, with the remainder from Canada.Google announced last year that it was buying a 6.6% stake in the home security firm for $450 million in a deal that will allow it to provide service to customers of its Nest home security devices. ADT said that the companies will work to combine Nest products like cameras, thermostats, doorbells and alarm systems with ADT’s installation, service and professional monitoring network. The company expects to expand the integration this year and beyond.RBC Capital Markets has resumed coverage of ADT stock with a $12 price target. The consensus target is $10.89. The shares closed trading on Friday at $7.57.Arcos DoradosThis company may be way under the radar, but it has one of the best products imaginable in terms of name recognition. Arcos Dorados Holdings Inc. (NYSE: ARCO) is the world’s largest independent McDonald’s franchisee.The company has the exclusive right to own, operate and grant franchises of McDonald’s restaurants in 20 countries and territories in Latin America and the Caribbean, including Brazil, Colombia, Costa Rica, Mexico, Puerto Rico, the U.S. Virgin Islands and Venezuela. As of December 31, 2020, it operated or franchised 2,236 restaurants.Credit Suisse’s $9.50 price target is above the $8.09 consensus target on Arcos Dorados stock. Shares last traded at $8.04 on Friday up almost 7%.LantronixThis company is producing solid revenue and is a great idea for aggressive traders. Lantronix Inc. (NASDAQ: LTRX) provides software as a service (SaaS), engineering services, and hardware for edge computing, the Internet of Things (IoT), and remote environment management (REM) in the Americas, Europe, the Middle East, Africa, and the Asia Pacific Japan.The company’s IoT products include IoT Connectivity, which provides wired and wireless connections that enhance the value and utility of modern electronic systems and equipment through secure network connectivity, application hosting, protocol conversion, secure access for distributed IoT deployments, and various other functions.Further, its SaaS platform enables customers to deploy, monitor, manage and automate across their global deployments through a single platform login. The company offers its products through value-added resellers, systems integrators, distributors, online retailers and original equipment manufacturers, and it has an e-commerce site for direct sales. Lantronix was founded in 1989 and is headquartered in Irvine, California.The $13 Canaccord Genuity price objective compares with a $12.69 consensus target. Lantronix stock traded on Friday at $6.58 down over 4%.Limelight NetworksThis stock looks to have bottomed recently, and it could be ready for a sizable move higher. Limelight Networks Inc. (NASDAQ: LLNW) offers services and solutions for businesses to deliver their digital content across the internet, mobile, social and other digital initiatives. It operates edge services platform that provides content delivery services, video content management services, performance services for website and web application acceleration and security, professional services, cloud storage and edge computing services, as well as sells equipment.Limelight Networks also offers professional services and other infrastructure services, such as transit and rack space services. It serves media companies operating in the television, music, radio, newspaper, magazine, movie, gaming, software and social media industries, as well as enterprises, technology companies and government entities conducting business online.A recent upgrade of Limelight Networks stock at Northland Capital included the $5 price target hiked to $6.50. The consensus target is $5.50, and the shares last traded at $4.78 on Friday.NokiaThis telecommunications company ruled the cell phone arena until the advent of the smartphone in 2007 and recently re-emerged as a top meme stock. Nokia Corp. (NYSE: NOK) owns two main businesses: 1) Nokia Networks, a network infrastructure equipment supplier to global wireless and wireline operators, and 2) Technologies, its patent/IPR licensing activities.In a very positive sign for investors this past week, the company restarted its quarterly dividend and initiated a share buyback program after reporting very solid fourth-quarter results, with comparable operating earnings above market estimates as the telecom equipment maker kept costs in check. Nokia also forecasted annual revenue that was largely ahead of projections and set a long-term target for operating margins of at least 14%, replacing its earlier 2023 target of between 11% and 13%.Raymond James upgraded Nokia stock recently and has a $6.50 target price. That is lower than the $7.23 consensus target but higher than a last share price of $5.33 seen on Friday.These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9094101787,"gmtCreate":1645071632768,"gmtModify":1676533994345,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Wow 😎","listText":"Wow 😎","text":"Wow 😎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094101787","repostId":"2211661523","repostType":2,"repost":{"id":"2211661523","pubTimestamp":1645057250,"share":"https://ttm.financial/m/news/2211661523?lang=&edition=fundamental","pubTime":"2022-02-17 08:20","market":"us","language":"en","title":"2 Warren Buffett Stocks to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2211661523","media":"Motley Fool","summary":"The Oracle of Omaha has historically beaten the market, so it might not be a bad thing to pick up a few tips from him.","content":"<html><head></head><body><p>Warren Buffett, CEO of multinational conglomerate <b>Berkshire Hathaway</b>, is widely regarded as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.</p><p>Buffett oversees his company&#39;s investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker <b>AbbVie</b> (NYSE:ABBV) and tech giant <b>Apple</b> (NASDAQ:AAPL). Here&#39;s why.</p><p><img src=\"https://static.tigerbbs.com/cbce34f9cdc257bf6d296c2baea0e809\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>ABBV Total Return Level data by YCharts</p><h2>1. AbbVie</h2><p>Pharmaceutical companies have the advantage of offering products that are always in demand. AbbVie&#39;s portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.</p><p>In 2021, AbbVie&#39;s net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That&#39;s a solid top-line performance for a pharma giant. The drugmaker&#39;s adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie&#39;s Humira made up almost 37% of the company&#39;s total revenue last year.</p><p>That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira&#39;s loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.</p><p>Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira&#39;s indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.</p><p>Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company&#39;s products boast patents that won&#39;t expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company&#39;s revenue base routinely.</p><p>AbbVie&#39;s solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.</p><p>That&#39;s just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.</p><h2>2. Apple</h2><p>Apple&#39;s iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.</p><p>Could Apple lose its dominance in the smartphone market? It wouldn&#39;t be the first time something like that happens. Apple itself played an instrumental role in the decline of <b>BlackBerry</b>&#39;s once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?</p><p>Given how popular and powerful the company&#39;s brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.</p><p>The company&#39;s services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple&#39;s services revenue grows -- and as it captures a larger share of the company&#39;s total revenue -- that will work wonders for the company&#39;s bottom line.</p><p>iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company&#39;s future is increasingly tied to its services segment, and that&#39;s something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett&#39;s portfolio.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Stocks to Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Stocks to Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-17 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4176":"多领域控股","BK4515":"5G概念","AAPL":"苹果","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4139":"生物科技","BK4553":"喜马拉雅资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4505":"高瓴资本持仓","BRK.A":"伯克希尔","BK4566":"资本集团","BK4507":"流媒体概念","BRK.B":"伯克希尔B","BK4554":"元宇宙及AR概念","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","BK4501":"段永平概念"},"source_url":"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211661523","content_text":"Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.Buffett oversees his company's investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker AbbVie (NYSE:ABBV) and tech giant Apple (NASDAQ:AAPL). Here's why.ABBV Total Return Level data by YCharts1. AbbViePharmaceutical companies have the advantage of offering products that are always in demand. AbbVie's portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.In 2021, AbbVie's net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That's a solid top-line performance for a pharma giant. The drugmaker's adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie's Humira made up almost 37% of the company's total revenue last year.That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira's loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira's indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company's products boast patents that won't expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company's revenue base routinely.AbbVie's solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.That's just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.2. AppleApple's iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.Could Apple lose its dominance in the smartphone market? It wouldn't be the first time something like that happens. Apple itself played an instrumental role in the decline of BlackBerry's once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?Given how popular and powerful the company's brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.The company's services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple's services revenue grows -- and as it captures a larger share of the company's total revenue -- that will work wonders for the company's bottom line.iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company's future is increasingly tied to its services segment, and that's something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett's portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007732876,"gmtCreate":1643001369100,"gmtModify":1676533764110,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"☕️😎✔️","listText":"☕️😎✔️","text":"☕️😎✔️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007732876","repostId":"2205027031","repostType":2,"repost":{"id":"2205027031","pubTimestamp":1642988892,"share":"https://ttm.financial/m/news/2205027031?lang=&edition=fundamental","pubTime":"2022-01-24 09:48","market":"us","language":"en","title":"Want 98% to 148% Returns This Year? Wall Street Says Buy These 3 Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2205027031","media":"Motley Fool","summary":"All three are innovators in their respective markets.","content":"<html><head></head><body><p>Wall Street doesn&#39;t always get it right. Some stocks that analysts really like don&#39;t perform well. Others that they dislike can be surprising stars.</p><p>However, analysts spend a lot of time poring over companies&#39; financial reports and researching their businesses and industry trends. They do plenty of number crunching to come up with price targets for stocks.</p><p>It&#39;s probably fair to say that the stocks that analysts are most bullish about have at least reasonable prospects of generating solid gains. And some of those stocks could be especially big winners. If you want returns of 98% to 148% this year, Wall Street analysts think that buying these three stocks could do the trick.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4829f7c425772aea60edd8d81cf4be5a\" tg-width=\"700\" tg-height=\"393\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>1. Shopify</h2><p><b>Shopify</b> (NYSE:SHOP) is an e-commerce leader that analysts really like these days. The stock delivered a 22% gain in 2021. Wall Street&#39;s consensus price target for Shopify is 148% higher than the current share price.</p><p>Sure, Shopify&#39;s valuation might seem terrifyingly high. The stock trades at almost 44 times sales and nearly 278 times expected earnings. However, it&#39;s important to put this premium valuation into context.</p><p>The total addressable market for Shopify in serving small- to medium-sized businesses (SMB) is more than $150 billion per year. Shopify isn&#39;t limited to the SMB market, though. The company also caters to entrepreneurial start-ups and large customers.</p><p>Shopify is growing rapidly, with revenue soaring 46% year over year in its latest reported quarter. The company will need to avoid missteps (such as the recent changes to its app store that displeased customers) to keep that momentum going. Barring any major blunders in the future, Shopify should be in a good position to deliver impressive returns for investors in 2022.</p><h2>2. Sea Limited</h2><p>If 2021 had ended in October, <b>Sea Limited</b> (NYSE:SE) would have delivered a sizzling gain last year. However, the stock plunged in the final couple of months and ended the year up only 12%.</p><p>But Wall Street analysts think that Sea could make a major comeback in 2022. The average price target for the stock reflects an upside potential of 140%. There are several reasons to be optimistic about the prospects for Sea to double or more this year.</p><p>Sea&#39;s <i>Free Fire</i> mobile game continues to pick up momentum -- and not just in Southeast Asia, where it has dominated for several years. It&#39;s also the highest-grossing mobile game in Latin America. Free Fire ranks as the highest-grossing mobile battle royale game in the U.S. and the second highest-grossing mobile game overall on Google Play.</p><p>Don&#39;t think of Sea Limited as only a video game stock, though. The company also stands as a leader in e-commerce with its Shopee platform. Shopee is the top e-commerce app in Southeast Asia, Indonesia, and Taiwan. It&#39;s gaining traction in Latin America as well, especially in Brazil. Sea&#39;s mobile wallet payment volume has also increased tremendously thanks in large part to Shopee&#39;s success.</p><p>There aren&#39;t many companies that claim leading positions in gaming, e-commerce, and digital payments. All three are key trends with lots of growth potential. Perhaps Sea Limited won&#39;t live up to analysts&#39; expectations this year, but it won&#39;t be surprising if it does.</p><h2>3. Teladoc Health</h2><p>Some might be tempted to throw in the towel on <b>Teladoc Health</b> (NYSE:TDOC). Shares of the virtual care provider lost more than half of its market cap last year. However, analysts remain very bullish about Teladoc. The average price target for the stock reflects a premium of 98% to the current share price.</p><p>Teladoc doesn&#39;t have to look very far to find growth opportunities. The company currently has 76 million members. There are another 16 million potential members at existing clients who haven&#39;t enrolled in Teladoc&#39;s virtual care offerings. And there are an additional 63 million individuals within existing clients that don&#39;t yet have access to any of Teladoc&#39;s products.</p><p>Increased product penetration is another way for Teladoc to grow. The penetration rate for the company&#39;s chronic disease management platform for diabetes is only around 21% right now. Less than 1% of members currently use Teladoc&#39;s new Primary360 virtual primary care product.</p><p>Of course, Teladoc also has significant room for bringing on new customers. More than 140 million Americans don&#39;t use Teladoc yet.</p><p>Consulting firm McKinsey &amp; Company estimates that the U.S. virtual care market could reach up to $250 billion per year. Teladoc is the leader in this market and should retain its position despite increased competition. Maybe the stock won&#39;t nearly double this year as Wall Street expects. However, Teladoc should be able to deliver huge gains over the long run.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want 98% to 148% Returns This Year? Wall Street Says Buy These 3 Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant 98% to 148% Returns This Year? Wall Street Says Buy These 3 Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-24 09:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/23/wall-street-says-buy-these-3-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street doesn't always get it right. Some stocks that analysts really like don't perform well. Others that they dislike can be surprising stars.However, analysts spend a lot of time poring over ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/23/wall-street-says-buy-these-3-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4116":"互联网服务与基础架构","TDOC":"Teladoc Health Inc.","SHOP":"Shopify Inc","BK4139":"生物科技","SMB":"VanEck Short Muni ETF","BGNE":"百济神州","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4503":"景林资产持仓","BK4505":"高瓴资本持仓","BK4085":"互动家庭娱乐","BK4566":"资本集团","BK4528":"SaaS概念","BK4551":"寇图资本持仓","BK4554":"元宇宙及AR概念","BK4167":"医疗保健技术","SE":"Sea Ltd","BK4504":"桥水持仓","BK4526":"热门中概股","BK4534":"瑞士信贷持仓","BK4567":"ESG概念"},"source_url":"https://www.fool.com/investing/2022/01/23/wall-street-says-buy-these-3-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205027031","content_text":"Wall Street doesn't always get it right. Some stocks that analysts really like don't perform well. Others that they dislike can be surprising stars.However, analysts spend a lot of time poring over companies' financial reports and researching their businesses and industry trends. They do plenty of number crunching to come up with price targets for stocks.It's probably fair to say that the stocks that analysts are most bullish about have at least reasonable prospects of generating solid gains. And some of those stocks could be especially big winners. If you want returns of 98% to 148% this year, Wall Street analysts think that buying these three stocks could do the trick.Image source: Getty Images.1. ShopifyShopify (NYSE:SHOP) is an e-commerce leader that analysts really like these days. The stock delivered a 22% gain in 2021. Wall Street's consensus price target for Shopify is 148% higher than the current share price.Sure, Shopify's valuation might seem terrifyingly high. The stock trades at almost 44 times sales and nearly 278 times expected earnings. However, it's important to put this premium valuation into context.The total addressable market for Shopify in serving small- to medium-sized businesses (SMB) is more than $150 billion per year. Shopify isn't limited to the SMB market, though. The company also caters to entrepreneurial start-ups and large customers.Shopify is growing rapidly, with revenue soaring 46% year over year in its latest reported quarter. The company will need to avoid missteps (such as the recent changes to its app store that displeased customers) to keep that momentum going. Barring any major blunders in the future, Shopify should be in a good position to deliver impressive returns for investors in 2022.2. Sea LimitedIf 2021 had ended in October, Sea Limited (NYSE:SE) would have delivered a sizzling gain last year. However, the stock plunged in the final couple of months and ended the year up only 12%.But Wall Street analysts think that Sea could make a major comeback in 2022. The average price target for the stock reflects an upside potential of 140%. There are several reasons to be optimistic about the prospects for Sea to double or more this year.Sea's Free Fire mobile game continues to pick up momentum -- and not just in Southeast Asia, where it has dominated for several years. It's also the highest-grossing mobile game in Latin America. Free Fire ranks as the highest-grossing mobile battle royale game in the U.S. and the second highest-grossing mobile game overall on Google Play.Don't think of Sea Limited as only a video game stock, though. The company also stands as a leader in e-commerce with its Shopee platform. Shopee is the top e-commerce app in Southeast Asia, Indonesia, and Taiwan. It's gaining traction in Latin America as well, especially in Brazil. Sea's mobile wallet payment volume has also increased tremendously thanks in large part to Shopee's success.There aren't many companies that claim leading positions in gaming, e-commerce, and digital payments. All three are key trends with lots of growth potential. Perhaps Sea Limited won't live up to analysts' expectations this year, but it won't be surprising if it does.3. Teladoc HealthSome might be tempted to throw in the towel on Teladoc Health (NYSE:TDOC). Shares of the virtual care provider lost more than half of its market cap last year. However, analysts remain very bullish about Teladoc. The average price target for the stock reflects a premium of 98% to the current share price.Teladoc doesn't have to look very far to find growth opportunities. The company currently has 76 million members. There are another 16 million potential members at existing clients who haven't enrolled in Teladoc's virtual care offerings. And there are an additional 63 million individuals within existing clients that don't yet have access to any of Teladoc's products.Increased product penetration is another way for Teladoc to grow. The penetration rate for the company's chronic disease management platform for diabetes is only around 21% right now. Less than 1% of members currently use Teladoc's new Primary360 virtual primary care product.Of course, Teladoc also has significant room for bringing on new customers. More than 140 million Americans don't use Teladoc yet.Consulting firm McKinsey & Company estimates that the U.S. virtual care market could reach up to $250 billion per year. Teladoc is the leader in this market and should retain its position despite increased competition. Maybe the stock won't nearly double this year as Wall Street expects. However, Teladoc should be able to deliver huge gains over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006707851,"gmtCreate":1641830701688,"gmtModify":1676533652259,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Cool &nbsp;😎&nbsp;","listText":"Cool &nbsp;😎&nbsp;","text":"Cool 😎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006707851","repostId":"1174204923","repostType":4,"repost":{"id":"1174204923","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641825188,"share":"https://ttm.financial/m/news/1174204923?lang=&edition=fundamental","pubTime":"2022-01-10 22:33","market":"us","language":"en","title":"Tilray shares rose over 13% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1174204923","media":"Tiger Newspress","summary":"Tilray shares rose over 13% in morning trading.Tilray Inc reported a 20% jump in second-quarter reve","content":"<html><head></head><body><p>Tilray shares rose over 13% in morning trading.<img src=\"https://static.tigerbbs.com/051bb047597cd7f60921251686efb4f1\" tg-width=\"1025\" tg-height=\"630\" width=\"100%\" height=\"auto\"/>Tilray Inc reported a 20% jump in second-quarter revenue on Monday, as the Canadian pot producer benefited from higher demand for cannabis and related products.</p><p>Pandemic-induced lockdowns have lifted demand for cannabis-related products from homebound customers, while the new marijuana sector-friendly policy changes including access to federal banking has sparked optimism among investors.</p><p>The world&#39;s largest cannabis producer by sales said its revenue rose to $155 million in the quarter ended Nov. 30 from $129 million a year earlier.</p><p>The company posted a net income of $6 million in the quarter, compared with a loss of $89 million a year earlier.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray shares rose over 13% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray shares rose over 13% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Tilray shares rose over 13% in morning trading.<img src=\"https://static.tigerbbs.com/051bb047597cd7f60921251686efb4f1\" tg-width=\"1025\" tg-height=\"630\" width=\"100%\" height=\"auto\"/>Tilray Inc reported a 20% jump in second-quarter revenue on Monday, as the Canadian pot producer benefited from higher demand for cannabis and related products.</p><p>Pandemic-induced lockdowns have lifted demand for cannabis-related products from homebound customers, while the new marijuana sector-friendly policy changes including access to federal banking has sparked optimism among investors.</p><p>The world&#39;s largest cannabis producer by sales said its revenue rose to $155 million in the quarter ended Nov. 30 from $129 million a year earlier.</p><p>The company posted a net income of $6 million in the quarter, compared with a loss of $89 million a year earlier.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TLRY":"Tilray Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174204923","content_text":"Tilray shares rose over 13% in morning trading.Tilray Inc reported a 20% jump in second-quarter revenue on Monday, as the Canadian pot producer benefited from higher demand for cannabis and related products.Pandemic-induced lockdowns have lifted demand for cannabis-related products from homebound customers, while the new marijuana sector-friendly policy changes including access to federal banking has sparked optimism among investors.The world's largest cannabis producer by sales said its revenue rose to $155 million in the quarter ended Nov. 30 from $129 million a year earlier.The company posted a net income of $6 million in the quarter, compared with a loss of $89 million a year earlier.","news_type":1},"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006704146,"gmtCreate":1641830315897,"gmtModify":1676533652242,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006704146","repostId":"1173383930","repostType":2,"repost":{"id":"1173383930","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641828185,"share":"https://ttm.financial/m/news/1173383930?lang=&edition=fundamental","pubTime":"2022-01-10 23:23","market":"us","language":"en","title":"Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1173383930","media":"Tiger Newspress","summary":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rate","content":"<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq falls 2%, Dow drops 500 points as Wall Street extends rough start for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 23:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.</p><p>TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&amp;P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.</p><p><img src=\"https://static.tigerbbs.com/3271886bd069566f888a2ed6fdbf7524\" tg-width=\"955\" tg-height=\"233\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173383930","content_text":"U.S. stocks fell Monday morning, extending a rocky start to 2022 for equity markets as interest rates rise.TheDow Jones Industrial Average dropped 518 points, or 1.4%. The S&P 500 shed 1.8% and the Nasdaq Composite slid 2.4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006704095,"gmtCreate":1641830298894,"gmtModify":1676533652224,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"OMG 😳&nbsp;","listText":"OMG 😳&nbsp;","text":"OMG 😳","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006704095","repostId":"1173383930","repostType":2,"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000225246,"gmtCreate":1640217097318,"gmtModify":1676533507697,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000225246","repostId":"2193511315","repostType":4,"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000293186,"gmtCreate":1640189161170,"gmtModify":1676533505940,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Good guide&nbsp;","listText":"Good guide&nbsp;","text":"Good guide","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000293186","repostId":"2193419144","repostType":2,"repost":{"id":"2193419144","pubTimestamp":1640179620,"share":"https://ttm.financial/m/news/2193419144?lang=&edition=fundamental","pubTime":"2021-12-22 21:27","market":"us","language":"en","title":"3 Leading Tech Stocks to Buy in 2022 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2193419144","media":"Motley Fool","summary":"These stocks are poised for a successful year.","content":"<p>With so many investment opportunities available, investing in category leaders is a good place to start. These businesses are typically lauded by customers and have better pricing power than smaller, less established players.</p>\n<p>Three leading tech stocks are&nbsp;<b>Nvidia</b> (NASDAQ:NVDA),&nbsp;<b>Ansys </b>(NASDAQ:ANSS), and&nbsp;<b>Match&nbsp;Group&nbsp;</b>(NASDAQ:MTCH). Each has competitors in their respective fields, but none do it better than these companies.</p>\n<h2>Nvidia: The leader in graphics</h2>\n<p>Nvidia makes graphics processing units (GPUs) that have historically been used for generating 3D graphics in computers and gaming systems. Now, this powerful hardware is seeing its usage expand into other solutions like artificial intelligence (AI) and cloud computing, creating a larger market for Nvidia to capture. As much as 70% of the world's 500 current most powerful computers and 90% of new systems utilize Nvidia's GPUs.</p>\n<p>This leader has seen tremendous business success over the last few quarters. During its third quarter ending Oct. 31, it grew revenue 65.2% to $7.1 billion. Even more impressive is its accelerating gross margin.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th colspan=\"5\">Quarterly Gross Margin</th>\n  </tr>\n  <tr>\n   <th>Q3 FY22</th>\n   <th>Q2 FY22</th>\n   <th>Q1 FY22</th>\n   <th>Q4 FY21</th>\n   <th>Q3 FY21</th>\n  </tr>\n  <tr>\n   <td>67%</td>\n   <td>66.7%</td>\n   <td>66.2%</td>\n   <td>65.5%</td>\n   <td>65.5%</td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Nvidia.</p>\n<p>Accelerating gross margin demonstrates a business's ability to flex its pricing power. Whether it means raising consumer prices to generate more revenue, creating products more efficiently and lowering the cost of goods, or pressuring suppliers into cutting their prices, pricing power is Warren Buffett's \"single most important factor when evaluating a business.\"</p>\n<p>As more powerful computers are needed to support cloud infrastructure, Nvidia's market opportunity will increase in lockstep. Nvidia also has technology in the autonomous vehicle sector and the metaverse. With a best-in-class product line and involvement with some of the most exciting future developments, Nvidia is poised as a great investment.</p>\n<h2>Ansys: The leader in engineering simulations</h2>\n<p>In the past, trial and error was an expensive way to determine whether a part would work. However, there was no other way to test if an idea was valid. Now, engineers can run their design through simulation software to gain valuable insights and optimize the design, all while reducing development costs. Ansys is the leader in engineering simulation software and is double the size of its nearest competitor.</p>\n<p>While other competitors have multiple segments, Ansys is focused on simulation software. By keying in on this area, Ansys offers solutions in many fields like optical, semiconductors, and fluids where competitors offer a couple. This allows Ansys software programs to integrate with each other and create layered solutions like structural and thermal analysis on a circuit board. Tying in with Nvidia, computers utilize GPUs when running simulations, demonstrating another use case for Nvidia's products.</p>\n<p>Ansys' third-quarter revenue increased 20% and turned 86% of it into gross profit. This led to a GAAP and non-GAAP operating margin of 24.4% and 39.7%, showcasing its strong profitability. Looking forward to the fourth quarter, ANSYS guided negative revenue growth on the low end and 4% growth at the top. While this might disappoint investors, in the previous two years, ANSYS exceeded its top-end internal revenue guidance by 2.3% (2019) and 7.3% (2020). Past results aren't a perfect predictor of what will happen in the future, but management has been known to over-deliver.</p>\n<p>As products become more complex, engineering simulation use will only increase. Ansys is positioned to lead the way.</p>\n<h2>Match Group: The leader in online dating</h2>\n<p>Today, 40% of relationships begin online, according to Match Group, which has a strong foothold in the space. Business of Apps found Match Group's platforms made up five of the top seven U.S. dating apps, capturing 72% of total users. Match Group has also been innovating, adding features like voices to dating profiles and video rooms.</p>\n<p>Revenue increased by 25% during Q3, with the Asia-Pacific region driving the most growth at 59%. This region also generated the most revenue per payer (RPP) at $17.71. The Asia-Pacific region has a much higher population than the Americas and Europe, giving Match Group plenty of payers to capture.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th colspan=\"3\">Paying Customers</th>\n  </tr>\n  <tr>\n   <th>Region</th>\n   <th>Payers (Millions)</th>\n   <th>Growth (YOY)</th>\n  </tr>\n  <tr>\n   <td>Americas</td>\n   <td>8.309</td>\n   <td>11%</td>\n  </tr>\n  <tr>\n   <td>Europe</td>\n   <td>4.710</td>\n   <td>13%</td>\n  </tr>\n  <tr>\n   <td>Asia-Pacific &amp; Others</td>\n   <td>3.284</td>\n   <td>36%</td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Match Group. YOY = year-over-year.</p>\n<p>With its most profitable region growing the fastest and a huge market opportunity, investors should be excited to see if Match can expand these results in 2022.</p>\n<h2>Winning in their categories</h2>\n<p>Over the last year, Nvidia has outperformed the market significantly, where Ansys and Match Group have struggled.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/52133a1a2318a7617c87b408c76ab815\" tg-width=\"720\" tg-height=\"387\" width=\"100%\" height=\"auto\"><span>NVDA data by YCharts</span></p>\n<p>After a down year, Ansys and Match Group investors will need to see some results or long-term investors may become impatient. Returns are correlated with quarterly results in the long run, so if Ansys and Match Group continue to execute, their stock performance will follow.</p>\n<p>Buying leaders like Nvidia, Ansys, and Match Group can be a formula for success as an investor. Each operates in an important industry with a tailwind blowing in their favor. As 2022 nears, consider buying these leaders with a mindset of holding for three to five years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Leading Tech Stocks to Buy in 2022 and Beyond</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Leading Tech Stocks to Buy in 2022 and Beyond\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 21:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/22/3-leading-tech-stocks-to-buy-in-2022-and-beyond/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With so many investment opportunities available, investing in category leaders is a good place to start. These businesses are typically lauded by customers and have better pricing power than smaller, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/22/3-leading-tech-stocks-to-buy-in-2022-and-beyond/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","MTCH":"Match Group, Inc.","ANSS":"安斯科技"},"source_url":"https://www.fool.com/investing/2021/12/22/3-leading-tech-stocks-to-buy-in-2022-and-beyond/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193419144","content_text":"With so many investment opportunities available, investing in category leaders is a good place to start. These businesses are typically lauded by customers and have better pricing power than smaller, less established players.\nThree leading tech stocks are Nvidia (NASDAQ:NVDA), Ansys (NASDAQ:ANSS), and Match Group (NASDAQ:MTCH). Each has competitors in their respective fields, but none do it better than these companies.\nNvidia: The leader in graphics\nNvidia makes graphics processing units (GPUs) that have historically been used for generating 3D graphics in computers and gaming systems. Now, this powerful hardware is seeing its usage expand into other solutions like artificial intelligence (AI) and cloud computing, creating a larger market for Nvidia to capture. As much as 70% of the world's 500 current most powerful computers and 90% of new systems utilize Nvidia's GPUs.\nThis leader has seen tremendous business success over the last few quarters. During its third quarter ending Oct. 31, it grew revenue 65.2% to $7.1 billion. Even more impressive is its accelerating gross margin.\n\n\n\nQuarterly Gross Margin\n\n\nQ3 FY22\nQ2 FY22\nQ1 FY22\nQ4 FY21\nQ3 FY21\n\n\n67%\n66.7%\n66.2%\n65.5%\n65.5%\n\n\n\nData source: Nvidia.\nAccelerating gross margin demonstrates a business's ability to flex its pricing power. Whether it means raising consumer prices to generate more revenue, creating products more efficiently and lowering the cost of goods, or pressuring suppliers into cutting their prices, pricing power is Warren Buffett's \"single most important factor when evaluating a business.\"\nAs more powerful computers are needed to support cloud infrastructure, Nvidia's market opportunity will increase in lockstep. Nvidia also has technology in the autonomous vehicle sector and the metaverse. With a best-in-class product line and involvement with some of the most exciting future developments, Nvidia is poised as a great investment.\nAnsys: The leader in engineering simulations\nIn the past, trial and error was an expensive way to determine whether a part would work. However, there was no other way to test if an idea was valid. Now, engineers can run their design through simulation software to gain valuable insights and optimize the design, all while reducing development costs. Ansys is the leader in engineering simulation software and is double the size of its nearest competitor.\nWhile other competitors have multiple segments, Ansys is focused on simulation software. By keying in on this area, Ansys offers solutions in many fields like optical, semiconductors, and fluids where competitors offer a couple. This allows Ansys software programs to integrate with each other and create layered solutions like structural and thermal analysis on a circuit board. Tying in with Nvidia, computers utilize GPUs when running simulations, demonstrating another use case for Nvidia's products.\nAnsys' third-quarter revenue increased 20% and turned 86% of it into gross profit. This led to a GAAP and non-GAAP operating margin of 24.4% and 39.7%, showcasing its strong profitability. Looking forward to the fourth quarter, ANSYS guided negative revenue growth on the low end and 4% growth at the top. While this might disappoint investors, in the previous two years, ANSYS exceeded its top-end internal revenue guidance by 2.3% (2019) and 7.3% (2020). Past results aren't a perfect predictor of what will happen in the future, but management has been known to over-deliver.\nAs products become more complex, engineering simulation use will only increase. Ansys is positioned to lead the way.\nMatch Group: The leader in online dating\nToday, 40% of relationships begin online, according to Match Group, which has a strong foothold in the space. Business of Apps found Match Group's platforms made up five of the top seven U.S. dating apps, capturing 72% of total users. Match Group has also been innovating, adding features like voices to dating profiles and video rooms.\nRevenue increased by 25% during Q3, with the Asia-Pacific region driving the most growth at 59%. This region also generated the most revenue per payer (RPP) at $17.71. The Asia-Pacific region has a much higher population than the Americas and Europe, giving Match Group plenty of payers to capture.\n\n\n\nPaying Customers\n\n\nRegion\nPayers (Millions)\nGrowth (YOY)\n\n\nAmericas\n8.309\n11%\n\n\nEurope\n4.710\n13%\n\n\nAsia-Pacific & Others\n3.284\n36%\n\n\n\nData source: Match Group. YOY = year-over-year.\nWith its most profitable region growing the fastest and a huge market opportunity, investors should be excited to see if Match can expand these results in 2022.\nWinning in their categories\nOver the last year, Nvidia has outperformed the market significantly, where Ansys and Match Group have struggled.\nNVDA data by YCharts\nAfter a down year, Ansys and Match Group investors will need to see some results or long-term investors may become impatient. Returns are correlated with quarterly results in the long run, so if Ansys and Match Group continue to execute, their stock performance will follow.\nBuying leaders like Nvidia, Ansys, and Match Group can be a formula for success as an investor. Each operates in an important industry with a tailwind blowing in their favor. As 2022 nears, consider buying these leaders with a mindset of holding for three to five years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9094101787,"gmtCreate":1645071632768,"gmtModify":1676533994345,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Wow 😎","listText":"Wow 😎","text":"Wow 😎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9094101787","repostId":"2211661523","repostType":2,"repost":{"id":"2211661523","pubTimestamp":1645057250,"share":"https://ttm.financial/m/news/2211661523?lang=&edition=fundamental","pubTime":"2022-02-17 08:20","market":"us","language":"en","title":"2 Warren Buffett Stocks to Buy and Hold Forever","url":"https://stock-news.laohu8.com/highlight/detail?id=2211661523","media":"Motley Fool","summary":"The Oracle of Omaha has historically beaten the market, so it might not be a bad thing to pick up a few tips from him.","content":"<html><head></head><body><p>Warren Buffett, CEO of multinational conglomerate <b>Berkshire Hathaway</b>, is widely regarded as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.</p><p>Buffett oversees his company&#39;s investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker <b>AbbVie</b> (NYSE:ABBV) and tech giant <b>Apple</b> (NASDAQ:AAPL). Here&#39;s why.</p><p><img src=\"https://static.tigerbbs.com/cbce34f9cdc257bf6d296c2baea0e809\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>ABBV Total Return Level data by YCharts</p><h2>1. AbbVie</h2><p>Pharmaceutical companies have the advantage of offering products that are always in demand. AbbVie&#39;s portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.</p><p>In 2021, AbbVie&#39;s net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That&#39;s a solid top-line performance for a pharma giant. The drugmaker&#39;s adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie&#39;s Humira made up almost 37% of the company&#39;s total revenue last year.</p><p>That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira&#39;s loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.</p><p>Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira&#39;s indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.</p><p>Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company&#39;s products boast patents that won&#39;t expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company&#39;s revenue base routinely.</p><p>AbbVie&#39;s solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.</p><p>That&#39;s just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.</p><h2>2. Apple</h2><p>Apple&#39;s iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.</p><p>Could Apple lose its dominance in the smartphone market? It wouldn&#39;t be the first time something like that happens. Apple itself played an instrumental role in the decline of <b>BlackBerry</b>&#39;s once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?</p><p>Given how popular and powerful the company&#39;s brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.</p><p>The company&#39;s services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple&#39;s services revenue grows -- and as it captures a larger share of the company&#39;s total revenue -- that will work wonders for the company&#39;s bottom line.</p><p>iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company&#39;s future is increasingly tied to its services segment, and that&#39;s something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett&#39;s portfolio.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Stocks to Buy and Hold Forever</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Stocks to Buy and Hold Forever\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-17 08:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4176":"多领域控股","BK4515":"5G概念","AAPL":"苹果","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4139":"生物科技","BK4553":"喜马拉雅资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4505":"高瓴资本持仓","BRK.A":"伯克希尔","BK4566":"资本集团","BK4507":"流媒体概念","BRK.B":"伯克希尔B","BK4554":"元宇宙及AR概念","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","BK4501":"段永平概念"},"source_url":"https://www.fool.com/investing/2022/02/16/2-warren-buffett-stocks-to-buy-and-hold-forever/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211661523","content_text":"Warren Buffett, CEO of multinational conglomerate Berkshire Hathaway, is widely regarded as one of the greatest investors of our time. That means we can all learn a lot from his buy-and-hold approach to investing and perhaps even get some much-needed inspiration from his stock picks.Buffett oversees his company's investment portfolio, and two stocks in there that are most definitely worth buying and holding onto today are drugmaker AbbVie (NYSE:ABBV) and tech giant Apple (NASDAQ:AAPL). Here's why.ABBV Total Return Level data by YCharts1. AbbViePharmaceutical companies have the advantage of offering products that are always in demand. AbbVie's portfolio includes immunology drugs Humira, Skyrizi, and Rinvoq; cancer medicines Imbruvica and Venclexta; and schizophrenia treatment Vraylar.In 2021, AbbVie's net revenue came in at $56.1 billion, 10.5% higher than the year-ago period. That's a solid top-line performance for a pharma giant. The drugmaker's adjusted earnings per share for the year increased 20.3% to $12.70. Note that AbbVie's Humira made up almost 37% of the company's total revenue last year.That is a problem since the healthcare company will lose patent exclusivity for this medicine in the U.S. next year. Humira's loss of patent exclusivity in Europe back in 2018 significantly harmed its international revenue.Still, the company is prepared to deal with the inevitable revenue losses Humira will experience in the U.S. in the coming years. Skyrizi and Rinvoq are well on their way to earning approvals across most of Humira's indications, and they already have significant wins under their belt. In 2021, Sales of Rinvoq more than doubled to $1.7 billion while revenue from Skyrizi increased by 85% to $2.9 billion.Skyrizi and Rinvoq seem well-equipped to fill the gaping hole that Humira will leave, but the company can count on its other products as well, including its Botox franchise. Many of the company's products boast patents that won't expire anytime soon. Plus, AbbVie has a pipeline with dozens of ongoing programs. Expect new approvals and label expansions to add to the company's revenue base routinely.AbbVie's solid business helps support its excellent dividend track record. The company is part of the exclusive club of Dividend Kings, or companies that have raised their payouts for at least 50 consecutive years. And with an above-average yield of 3.74% and a conservative payout ratio of 42%, AbbVie looks more than able to sustain further dividend increases ahead.That's just one more reason to purchase shares of this pharma giant. Overall, AbbVie looks like a solid company to hold on to through thick and thin.2. AppleApple's iPhone has been immensely successful since it was introduced in 2007. The company remains a leader in this industry with a 22% share of the smartphone market in the fourth quarter of 2021. During its fiscal year 2021 (ended Sept. 25), Apple generated $192 billion in sales from its iPhone segment, 39.3% higher than the previous fiscal year.Could Apple lose its dominance in the smartphone market? It wouldn't be the first time something like that happens. Apple itself played an instrumental role in the decline of BlackBerry's once-booming smartphone business starting in the late 2000s. Could other companies permanently dethrone Apple?Given how popular and powerful the company's brand has become, it is hard to imagine Apple no longer being one of the most prominent players in this field, at least for the foreseeable future. More importantly, though, Apple has leveraged its strong brand name and robust cash flow generation to invest in and grow its services business.The company's services segment offers customers a range of products, including Apple Music, Apple TV+, Apple Pay, iCloud, and more. The great thing about this business is that it offers much juicier margins than the sale of hardware products such as the iPhone, tablets, and laptops. In other words, as Apple's services revenue grows -- and as it captures a larger share of the company's total revenue -- that will work wonders for the company's bottom line.iPhone sales will likely remain strong for many more years, especially as Apple makes headway into various international markets. But the company's future is increasingly tied to its services segment, and that's something that should excite investors. Even with a $2.8 trillion market cap, Apple still has considerable room to grow. No wonder it is one of the largest holdings in Buffett's portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006704146,"gmtCreate":1641830315897,"gmtModify":1676533652242,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006704146","repostId":"1173383930","repostType":2,"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007732876,"gmtCreate":1643001369100,"gmtModify":1676533764110,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"☕️😎✔️","listText":"☕️😎✔️","text":"☕️😎✔️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007732876","repostId":"2205027031","repostType":2,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006704095,"gmtCreate":1641830298894,"gmtModify":1676533652224,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"OMG 😳&nbsp;","listText":"OMG 😳&nbsp;","text":"OMG 😳","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006704095","repostId":"1173383930","repostType":2,"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000225246,"gmtCreate":1640217097318,"gmtModify":1676533507697,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000225246","repostId":"2193511315","repostType":4,"repost":{"id":"2193511315","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640215949,"share":"https://ttm.financial/m/news/2193511315?lang=&edition=fundamental","pubTime":"2021-12-23 07:32","market":"us","language":"en","title":"Novavax says COVID vaccine triggers immune response to Omicron variant","url":"https://stock-news.laohu8.com/highlight/detail?id=2193511315","media":"Reuters","summary":"Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response agai","content":"<p>Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n<p>Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.</p>\n<p>Novavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p>\n<p>\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.</p>\n<p>Other COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.</p>\n<p>Novavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.</p>\n<p>The drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.</p>\n<p>The company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine. </p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax says COVID vaccine triggers immune response to Omicron variant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax says COVID vaccine triggers immune response to Omicron variant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 07:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n<p>Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.</p>\n<p>Novavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.</p>\n<p>\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.</p>\n<p>Other COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.</p>\n<p>Novavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.</p>\n<p>The drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.</p>\n<p>The company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine. </p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","BK4139":"生物科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193511315","content_text":"Dec 22 (Reuters) - Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.\nNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization. It has previously been approved by countries including Indonesia and the Philippines but not the United States.\nNovavax said that receiving an additional booster dose of Novavax's vaccine further increased people's immune response to Omicron. The data was taken from Novavax's ongoing studies of its vaccine's effectiveness in adolescents and as a booster.\n\"We are encouraged that boosted responses against all variants were comparable to those associated with high vaccine efficacy in our Phase 3 clinical trials,” said Gregory M. Glenn, Novavax's president of research and development.\nOther COVID-19 vaccine manufacturers, including Pfizer Inc. and Moderna Inc., also increase immune responses to Omicron, early data from those companies has shown. Resistance in all cases is stronger in people who have received an additional booster dose.\nNovavax is working on developing an Omicron-specific vaccine and said Wednesday it expects to begin manufacturing doses of the variant-specific shot in January.\nThe drugmaker will start shipping vaccines to the EU's 27 member states in January as part of its deal to supply up to 200 million doses.\nThe company will also begin shipments in early 2022 to COVAX, a vaccine distribution mechanism overseen by WHO that allocates COVID-19 shots to poorer countries. Novavax and its partner, Serum Institute of India, have agreed to send COVAX more than 1.1 billion doses of Novavax's vaccine.","news_type":1},"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9034178284,"gmtCreate":1647838020118,"gmtModify":1676534270573,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Why my account still under review? any chance to activate real account please help","listText":"Why my account still under review? any chance to activate real account please help","text":"Why my account still under review? any chance to activate real account please help","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9034178284","repostId":"1148619313","repostType":2,"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006707851,"gmtCreate":1641830701688,"gmtModify":1676533652259,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Cool &nbsp;😎&nbsp;","listText":"Cool &nbsp;😎&nbsp;","text":"Cool 😎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006707851","repostId":"1174204923","repostType":4,"isVote":1,"tweetType":1,"viewCount":316,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000293186,"gmtCreate":1640189161170,"gmtModify":1676533505940,"author":{"id":"4100837542174330","authorId":"4100837542174330","authorIdStr":"4100837542174330","name":"Attan","avatar":"https://static.tigerbbs.com/d1ed57e21d55aaa066adceb77c7f9945","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4100837542174330"},"themes":[],"htmlText":"Good guide&nbsp;","listText":"Good guide&nbsp;","text":"Good guide","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000293186","repostId":"2193419144","repostType":2,"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}